zeeshan gauhar phd scholor-biotechnology 14-arid-4978
TRANSCRIPT
![Page 1: ZEESHAN GAUHAR PhD SCHOLOR-BIOTECHNOLOGY 14-ARID-4978](https://reader030.vdocuments.us/reader030/viewer/2022032604/56649e595503460f94b5353f/html5/thumbnails/1.jpg)
ZEESHAN GAUHAR
PhD SCHOLOR-BIOTECHNOLOGY
14-ARID-4978
HEREDITARY ATAXIA
![Page 2: ZEESHAN GAUHAR PhD SCHOLOR-BIOTECHNOLOGY 14-ARID-4978](https://reader030.vdocuments.us/reader030/viewer/2022032604/56649e595503460f94b5353f/html5/thumbnails/2.jpg)
Hereditary Ataxia Clinical manifestations Autosomal dominant hereditary ataxia Clinical features of ADCA Molecular genetic testing Other repeat expansions Prevalence Autosomal recessive hereditary ataxia Friedreich ataxia (FRDA) FXN YAC transgenic mouse models Therapeutic approaches References
contents
![Page 3: ZEESHAN GAUHAR PhD SCHOLOR-BIOTECHNOLOGY 14-ARID-4978](https://reader030.vdocuments.us/reader030/viewer/2022032604/56649e595503460f94b5353f/html5/thumbnails/3.jpg)
HEREDITARY ATAXIA
Clinically and genetically heterogeneous group of disorders characterized by slowly progressive incoordination of gait, poor coordination of hands, speech, and eye movements
![Page 4: ZEESHAN GAUHAR PhD SCHOLOR-BIOTECHNOLOGY 14-ARID-4978](https://reader030.vdocuments.us/reader030/viewer/2022032604/56649e595503460f94b5353f/html5/thumbnails/4.jpg)
Ataxia of gait
Dysarthria
Sensory deficits
Spasticity
Retinopathy and optic atrophy
Parkinsonian features
Epilepsy
Clinical manifestations
![Page 5: ZEESHAN GAUHAR PhD SCHOLOR-BIOTECHNOLOGY 14-ARID-4978](https://reader030.vdocuments.us/reader030/viewer/2022032604/56649e595503460f94b5353f/html5/thumbnails/5.jpg)
http://drugline.org/medic/term/ataxia/
![Page 6: ZEESHAN GAUHAR PhD SCHOLOR-BIOTECHNOLOGY 14-ARID-4978](https://reader030.vdocuments.us/reader030/viewer/2022032604/56649e595503460f94b5353f/html5/thumbnails/6.jpg)
Figure 1 Coronal brain MRI showing atrophy of both cerebellar hemispheres (arrows) in a 28-year-old woman with SCA2. MRI, magnetic resonance imaging; SCA, spinocerebellar ataxia
![Page 7: ZEESHAN GAUHAR PhD SCHOLOR-BIOTECHNOLOGY 14-ARID-4978](https://reader030.vdocuments.us/reader030/viewer/2022032604/56649e595503460f94b5353f/html5/thumbnails/7.jpg)
The hereditary ataxias can be inherited in 1. autosomal dominant2. autosomal recessive3. X- linked manner 4. Mitochondrial inheritance
![Page 8: ZEESHAN GAUHAR PhD SCHOLOR-BIOTECHNOLOGY 14-ARID-4978](https://reader030.vdocuments.us/reader030/viewer/2022032604/56649e595503460f94b5353f/html5/thumbnails/8.jpg)
Autosomal dominant cerebellar ataxia
![Page 9: ZEESHAN GAUHAR PhD SCHOLOR-BIOTECHNOLOGY 14-ARID-4978](https://reader030.vdocuments.us/reader030/viewer/2022032604/56649e595503460f94b5353f/html5/thumbnails/9.jpg)
![Page 10: ZEESHAN GAUHAR PhD SCHOLOR-BIOTECHNOLOGY 14-ARID-4978](https://reader030.vdocuments.us/reader030/viewer/2022032604/56649e595503460f94b5353f/html5/thumbnails/10.jpg)
![Page 11: ZEESHAN GAUHAR PhD SCHOLOR-BIOTECHNOLOGY 14-ARID-4978](https://reader030.vdocuments.us/reader030/viewer/2022032604/56649e595503460f94b5353f/html5/thumbnails/11.jpg)
![Page 12: ZEESHAN GAUHAR PhD SCHOLOR-BIOTECHNOLOGY 14-ARID-4978](https://reader030.vdocuments.us/reader030/viewer/2022032604/56649e595503460f94b5353f/html5/thumbnails/12.jpg)
![Page 13: ZEESHAN GAUHAR PhD SCHOLOR-BIOTECHNOLOGY 14-ARID-4978](https://reader030.vdocuments.us/reader030/viewer/2022032604/56649e595503460f94b5353f/html5/thumbnails/13.jpg)
![Page 14: ZEESHAN GAUHAR PhD SCHOLOR-BIOTECHNOLOGY 14-ARID-4978](https://reader030.vdocuments.us/reader030/viewer/2022032604/56649e595503460f94b5353f/html5/thumbnails/14.jpg)
Clinical features of ADCA Pyramidal signs (hyperreflexia and spasticity) in SCA1
and SCA3. Cognitive impairment in SCA2, SCA12, SCA13,
SCA17. Chorea in SCA17 Parkinsonism or motor neuron disease in SCA2
Autosomal dominant cerebellar ataxia
![Page 15: ZEESHAN GAUHAR PhD SCHOLOR-BIOTECHNOLOGY 14-ARID-4978](https://reader030.vdocuments.us/reader030/viewer/2022032604/56649e595503460f94b5353f/html5/thumbnails/15.jpg)
Mutations associated with the ADCAs include; point mutations duplications deletions nucleotide expansions
Molecular genetic testing
![Page 16: ZEESHAN GAUHAR PhD SCHOLOR-BIOTECHNOLOGY 14-ARID-4978](https://reader030.vdocuments.us/reader030/viewer/2022032604/56649e595503460f94b5353f/html5/thumbnails/16.jpg)
SCA1, SCA2, SCA3, SCA6, SCA7, SCA12, SCA17 and DRPLA are all caused by CAG repeats which results elongated polyglutamine tract in the protein.
The sizes of the normal CAG repeat allele and of the full-penetrance disease-causing CAG expansion vary among the disorders
![Page 17: ZEESHAN GAUHAR PhD SCHOLOR-BIOTECHNOLOGY 14-ARID-4978](https://reader030.vdocuments.us/reader030/viewer/2022032604/56649e595503460f94b5353f/html5/thumbnails/17.jpg)
SCA8 has a CTG trinucleotide repeat expansion in ATXN8OS.
The pathogenesis of the SCA8 phenotype also involves a (CAG)n repeat in a second overlapping gene, ATXN8.
SCA10 has a large expansion of an ATTCT pentanucleotide repeat in ATXN10
Other repeat expansions
![Page 18: ZEESHAN GAUHAR PhD SCHOLOR-BIOTECHNOLOGY 14-ARID-4978](https://reader030.vdocuments.us/reader030/viewer/2022032604/56649e595503460f94b5353f/html5/thumbnails/18.jpg)
Prevalence of these rare diseases is not widely known.◦ADCAs in the Netherlands is estimated to be at
least 3:100,000.◦DRPLA is more common in Japan ◦SCA3 in Portugal, Japan and Germany◦SCA2 is common in Korea
Prevalence
![Page 19: ZEESHAN GAUHAR PhD SCHOLOR-BIOTECHNOLOGY 14-ARID-4978](https://reader030.vdocuments.us/reader030/viewer/2022032604/56649e595503460f94b5353f/html5/thumbnails/19.jpg)
Autosomal recessive hereditary ataxias
![Page 20: ZEESHAN GAUHAR PhD SCHOLOR-BIOTECHNOLOGY 14-ARID-4978](https://reader030.vdocuments.us/reader030/viewer/2022032604/56649e595503460f94b5353f/html5/thumbnails/20.jpg)
One parent has ataxia and one parent is a carrier
![Page 21: ZEESHAN GAUHAR PhD SCHOLOR-BIOTECHNOLOGY 14-ARID-4978](https://reader030.vdocuments.us/reader030/viewer/2022032604/56649e595503460f94b5353f/html5/thumbnails/21.jpg)
Both parents are carriers
![Page 22: ZEESHAN GAUHAR PhD SCHOLOR-BIOTECHNOLOGY 14-ARID-4978](https://reader030.vdocuments.us/reader030/viewer/2022032604/56649e595503460f94b5353f/html5/thumbnails/22.jpg)
One parent is an unaffected carrier and the other is an unaffected non-carrier
![Page 23: ZEESHAN GAUHAR PhD SCHOLOR-BIOTECHNOLOGY 14-ARID-4978](https://reader030.vdocuments.us/reader030/viewer/2022032604/56649e595503460f94b5353f/html5/thumbnails/23.jpg)
![Page 24: ZEESHAN GAUHAR PhD SCHOLOR-BIOTECHNOLOGY 14-ARID-4978](https://reader030.vdocuments.us/reader030/viewer/2022032604/56649e595503460f94b5353f/html5/thumbnails/24.jpg)
![Page 25: ZEESHAN GAUHAR PhD SCHOLOR-BIOTECHNOLOGY 14-ARID-4978](https://reader030.vdocuments.us/reader030/viewer/2022032604/56649e595503460f94b5353f/html5/thumbnails/25.jpg)
13 typical autosomal recessive disorders in which ataxia is a prominent feature
Friedreich ataxia (FRDA) The most common autosomal recessive ataxia with a
population frequency of 1–2:50,000 Caused by a GAA repeat expansion mutation within
intron 1 of the FXN gene Result in reduced levels of frataxin protein
Autosomal recessive hereditary ataxias
![Page 26: ZEESHAN GAUHAR PhD SCHOLOR-BIOTECHNOLOGY 14-ARID-4978](https://reader030.vdocuments.us/reader030/viewer/2022032604/56649e595503460f94b5353f/html5/thumbnails/26.jpg)
The reduction in frataxin expression leads to oxidative stress, mitochondrial iron accumulation and consequential cell death with the primary sites of neurons of the dorsal root ganglia and the dentate nucleus of the cerebellum
![Page 27: ZEESHAN GAUHAR PhD SCHOLOR-BIOTECHNOLOGY 14-ARID-4978](https://reader030.vdocuments.us/reader030/viewer/2022032604/56649e595503460f94b5353f/html5/thumbnails/27.jpg)
Normal individuals have 5 to 40 GAA repeat sequences
affected individuals have approximately 70 to more than 1000 GAA triplets
Typically associated with depressed tendon reflexes, dysarthria, Babinski responses, and loss of position and vibration senses.
![Page 28: ZEESHAN GAUHAR PhD SCHOLOR-BIOTECHNOLOGY 14-ARID-4978](https://reader030.vdocuments.us/reader030/viewer/2022032604/56649e595503460f94b5353f/html5/thumbnails/28.jpg)
http://drugline.org/medic/term/ataxia/
![Page 29: ZEESHAN GAUHAR PhD SCHOLOR-BIOTECHNOLOGY 14-ARID-4978](https://reader030.vdocuments.us/reader030/viewer/2022032604/56649e595503460f94b5353f/html5/thumbnails/29.jpg)
To investigate FRDA molecular disease mechanisms and therapy, three human FXN YAC transgenic mouse models
• Y47R, containing normal-sized (GAA)9 repeats
• YG8R, containing expanded GAA repeats of 120–220 units• YG22R, containing 170–260 units
FXN YAC transgenic mouse models
![Page 30: ZEESHAN GAUHAR PhD SCHOLOR-BIOTECHNOLOGY 14-ARID-4978](https://reader030.vdocuments.us/reader030/viewer/2022032604/56649e595503460f94b5353f/html5/thumbnails/30.jpg)
First the difference in the FXN transgene copy number in YG8R, YG22R and Y47R lines were investigated and found that the YG22R and Y47R lines had a single copy of the FRDA transgene while the YG8R line had two copies of the FRDA transgene.
![Page 31: ZEESHAN GAUHAR PhD SCHOLOR-BIOTECHNOLOGY 14-ARID-4978](https://reader030.vdocuments.us/reader030/viewer/2022032604/56649e595503460f94b5353f/html5/thumbnails/31.jpg)
(a) Two TaqMan copy number assays were applied; Hs05092416-cn assay, represented in black, was designed to amplify a 106 bp fragment of FXN within intron 3 and Hs02407730-cn assay, represented in grey, was designed to amplify an 80 bp fragment of FXN within intron 1 and exon 2. Wild type (WT) served as a negative control with no copy number
![Page 32: ZEESHAN GAUHAR PhD SCHOLOR-BIOTECHNOLOGY 14-ARID-4978](https://reader030.vdocuments.us/reader030/viewer/2022032604/56649e595503460f94b5353f/html5/thumbnails/32.jpg)
YG22R and YG8R FRDA mice expressed comparatively decreased levels of human frataxin in comparison to the endogenous mouse levels.
To determine the effect of reduced frataxin level, coordination ability of YG8R and YG22R mice was assessed
The YG8R and YG22R showed a significant decline in their motor function compared to B6 and Y47R controls, though, the degree of impairment was more significant in YG8R mice.
![Page 33: ZEESHAN GAUHAR PhD SCHOLOR-BIOTECHNOLOGY 14-ARID-4978](https://reader030.vdocuments.us/reader030/viewer/2022032604/56649e595503460f94b5353f/html5/thumbnails/33.jpg)
YG22R and YG8R FRDA mice show a coordination deficit compared to B6 and Y47R controls when (a) both male and female values were taken together (n = 10 mice per genotype) or (b) male alone (n = 5 mice per genotype) or (c) female alone (n = 5 mice per genotype).
![Page 34: ZEESHAN GAUHAR PhD SCHOLOR-BIOTECHNOLOGY 14-ARID-4978](https://reader030.vdocuments.us/reader030/viewer/2022032604/56649e595503460f94b5353f/html5/thumbnails/34.jpg)
Resons Firstly, lower body weight of the females may have
contributed to the improved function of these mice. Secondly, females may be more capable of adapting to
the experimental environment and conditions compared to the male mice.
![Page 35: ZEESHAN GAUHAR PhD SCHOLOR-BIOTECHNOLOGY 14-ARID-4978](https://reader030.vdocuments.us/reader030/viewer/2022032604/56649e595503460f94b5353f/html5/thumbnails/35.jpg)
body weight analysis of YG22R and YG8R demonstrated an increase in weight compared to B6
GAA repeat instability in the brain and cerebellum of both YG22 and YG8 transgenic mice
Consistent reduction in the levels of frataxin mRNA and protein in the brain and liver samples of YG8R and YG22R mice compared to Y47R mice
Body weight analysis
![Page 36: ZEESHAN GAUHAR PhD SCHOLOR-BIOTECHNOLOGY 14-ARID-4978](https://reader030.vdocuments.us/reader030/viewer/2022032604/56649e595503460f94b5353f/html5/thumbnails/36.jpg)
Interferon gamma (IFNγ), a cytokine involved in multiple aspects of iron metabolism and the immune response , has been shown to increase frataxin levels in both cell and animal models of FRDA
It has been reported that in vivo treatment of YG8R mice with IFNγ enhances both locomotor activity and motor coordination, and induces the upregulation of cellular frataxin
Therapeutic approaches
![Page 37: ZEESHAN GAUHAR PhD SCHOLOR-BIOTECHNOLOGY 14-ARID-4978](https://reader030.vdocuments.us/reader030/viewer/2022032604/56649e595503460f94b5353f/html5/thumbnails/37.jpg)
Use of HDAC inhibitors as potent candidates to prevent deacetylation of histones and increase FXN gene transcription through relaxation of chromatin conformation
These studies are supported by the results from a five-month study on the YG8R mice which confirmed the positive effects of HDAC inhibitors by reversing frataxin gene silencing
![Page 38: ZEESHAN GAUHAR PhD SCHOLOR-BIOTECHNOLOGY 14-ARID-4978](https://reader030.vdocuments.us/reader030/viewer/2022032604/56649e595503460f94b5353f/html5/thumbnails/38.jpg)
Cellular, Molecular and Functional Characterisation of YAC Transgenic Mouse Models of Friedreich Ataxia Virmouni SA et al (2014)
Hereditary ataxias: overview Suman Jayadev, MD1 and Thomas D. Bird, MD (2013) Sandi C, Sandi M, Jassal H, Ezzatizadeh V, Anjomani-Virmouni S, et al. (2014) Generation
and characterisation of friedreich ataxia YG8R mouse fibroblast and neural stem cell models. PLoS One 9: e89488.doi: 10.1371/journal.pone.0089488[PMC free article [PubMed
References
![Page 39: ZEESHAN GAUHAR PhD SCHOLOR-BIOTECHNOLOGY 14-ARID-4978](https://reader030.vdocuments.us/reader030/viewer/2022032604/56649e595503460f94b5353f/html5/thumbnails/39.jpg)
THANKS